Patents by Inventor Rajendra Prasad Bandari

Rajendra Prasad Bandari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dual targeting ligand for cancer diagnosis and treatment
    Patent number: 11167048
    Abstract: Disclosed are compositions and methods relating to prostate cancer. In particular, disclosed are bivalent targeting ligands that specifically bind prostate specific membrane antigen and gastrin-releasing peptide receptor. Bivalent binding agents disclosed herein can be used to image a tissue in a subject in need thereof and to diagnose prostate cancer in a subject in need thereof. Bivalent binding agents disclosed herein can be used to treat prostate cancer in a subject in need thereof.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: November 9, 2021
    Assignee: The Curators of the University of Missouri
    Inventors: Charles Jeffrey Smith, Rajendra Prasad Bandari
  • NOVEL DUAL TARGETING LIGAND FOR CANCER DIAGNOSIS AND TREATMENT
    Publication number: 20200188539
    Abstract: Disclosed are compositions and methods relating to prostate cancer. In particular, disclosed are bivalent targeting ligands that specifically bind prostate specific membrane antigen and gastrin-releasing peptide receptor. Bivalent binding agents disclosed herein can be used to image a tissue in a subject in need thereof and to diagnose prostate cancer in a subject in need thereof. Bivalent binding agents disclosed herein can be used to treat prostate cancer in a subject in need thereof.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Inventors: Charles Jeffrey Smith, Rajendra Prasad Bandari
  • Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof
    Patent number: 7528128
    Abstract: The present invention provides a compound of general formula 5, useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula 5 wherein, X1, X2, X3 is selected from H or Cl or CH3, Y is selected from O or NH, Z is selected from C?O or CH2 and n=1 to 4.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: May 5, 2009
    Assignee: Council of Scientific & Industrial Research
    Inventors: Kamal Ahmed, Rajendra Prasad Bandari